X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 55 filers reported holding X4 PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $263,500 | -31.7% | 241,744 | +21.6% | 0.00% | – |
| Q2 2023 | $385,757 | +481.8% | 198,844 | +160.9% | 0.00% | – |
| Q1 2023 | $66,299 | -12.2% | 76,205 | +0.2% | 0.00% | – |
| Q4 2022 | $75,524 | -22.1% | 76,057 | +32.9% | 0.00% | – |
| Q3 2022 | $97,000 | +3133.3% | 57,237 | +1701.6% | 0.00% | – |
| Q2 2022 | $3,000 | -81.2% | 3,177 | -64.3% | 0.00% | – |
| Q1 2022 | $16,000 | -40.7% | 8,909 | -26.1% | 0.00% | – |
| Q4 2021 | $27,000 | -41.3% | 12,058 | +37.0% | 0.00% | – |
| Q3 2021 | $46,000 | -31.3% | 8,800 | -14.1% | 0.00% | – |
| Q2 2021 | $67,000 | +148.1% | 10,242 | +227.8% | 0.00% | – |
| Q1 2021 | $27,000 | -81.0% | 3,124 | -85.8% | 0.00% | – |
| Q4 2020 | $142,000 | +24.6% | 22,068 | +31.1% | 0.00% | – |
| Q3 2020 | $114,000 | -43.6% | 16,834 | -22.5% | 0.00% | – |
| Q2 2020 | $202,000 | +392.7% | 21,708 | +435.5% | 0.00% | – |
| Q1 2020 | $41,000 | -80.1% | 4,054 | -79.0% | 0.00% | – |
| Q4 2019 | $206,000 | +148.2% | 19,290 | +195.9% | 0.00% | – |
| Q3 2019 | $83,000 | +66.0% | 6,519 | +92.9% | 0.00% | – |
| Q2 2019 | $50,000 | +525.0% | 3,379 | +584.0% | 0.00% | – |
| Q1 2019 | $8,000 | – | 494 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 12,202,510 | $10,616 | 1.33% |
| Tri Locum Partners LP | 3,878,484 | $3,374,281 | 1.03% |
| Lynwood Capital Management Inc. | 900,000 | $783,000 | 0.71% |
| NEA Management Company, LLC | 11,736,793 | $10,211,010 | 0.71% |
| Parkman Healthcare Partners LLC | 2,797,147 | $2,433,518 | 0.53% |
| SCOGGIN MANAGEMENT LP | 484,796 | $567,025 | 0.33% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $291,450 | 0.24% |
| Ghost Tree Capital, LLC | 850,000 | $740,000 | 0.22% |
| Perceptive Advisors | 4,545,454 | $3,954,545 | 0.12% |
| Orbimed Advisors | 5,817,726 | $5,061,422 | 0.10% |